Myricx Bio

Business Health Europe

Novartis to Buy UK Biotech Myricx Bio for $1.5bn

Novartis is buying British biotech Myricx Bio for up to $1.5 billion to expand its cancer drug pipeline.

Novartis to buy UK biotech in $1.5bn deal Financial Times — Jul 06, 07:46 AM
Novartis to acquire UK-based Myricx Bio for $1.5 billion RTE — Jul 06, 07:29 AM
Novartis strikes $1.5B deal for UK biotech Myricx Bio Seeking Alpha — Jul 06, 07:15 AM
Novartis to Buy Cancer-Drug Firm Myricx for Up to $1.5 Billion Bloomberg — Jul 06, 06:58 AM